ABOUT OCULAR SCIENCE™

Ocular Science™ is an innovative biotech company based out of Manhattan Beach, California. In 2017, Ocular Science™ launched Omni™ post-operative drop care for patients who have had vision correction procedures and the management of glaucoma. Along with Genesis™, an amniotic cytokine extract, these post-operative drops are revolutionizing the patient experience, in addition to helping treat dry eye by reducing inflammation and facilitating healing of the ocular surface.

PRODUCTS

water droplet on leaf

Omni™

water droplets on grass

Genesis™

Post-operative drop care for vision correction patients and the management of glaucoma can be challenging and expensive. At Ocular Science™, we have developed and optimized Omni™ as a way to improve this essential part of the patient experience. Using Omni™, you can decrease your patients’ out-of-pocket expenses while providing them with a post-operative drop plan and an alternative glaucoma medication that promotes easy adherence, along with more reliable outcomes.

We created and optimized Omni™ to help physicians achieve the best patient outcomes at the lowest patient cost. These formulas promote rapid healing and are engineered with patient adherence in mind. Our goal is to simplify their drop regimens, resulting in an increased adherence rate and more reliable, positive outcomes.

All of our cataract, LASIK and retina formulations are water soluble, preservative-free and mild in nature. All of our unique formulations require less effort from the patient and lead to a higher rate of efficacy.

Our Omni™ product line includes three post-operative drop formulas, two injection formulas for the administration during surgery and three formulas for the management of glaucoma.

Lasik, Retina and Cataracts

PREDNISOLONE SODIUM PHOSPHATE AND GATIFLOXACIN OPHTHALMIC SOLUTION

A four-dose-per-day drop that combines a steroid and an antibiotic to reduce pain and inflammation in the eye

PREDNISOLONE SODIUM PHOSPHATE AND KETOROLAC TROMETHAMINE

A four-dose-per-day drop that combines a steroid and a nonsteroidal anti-inflammatory.

Read more about the proven effectiveness of:
Prednisolone Sodium Phosphate
Pred-Ketor combination

PREDNISOLONE SODIUM PHOSPHATE, GATIFLOXACIN OPHTHALMIC SOLUTION AND KETOROLAC TROMETHAMINE

A four-dose-per-day drop that combines a steroid, an antibiotic, and a non-steroidal anti-inflammatory.

Cataract Intracameral Injection

Video of Injection

DEXAMETHASONE OPHTHALMIC AND MOXIFLOXACIN HYDROCHLORIDE

The formula of these intracameral injections is completely clear, allowing a patient to leave your operating room without the milkiness that typically occurs with other post-op intravitreal injections. Using these injections can reduce the amount of eye drops prescribed post-operatively, lowering patient cost and allowing for more reliable, positive outcomes.

Read more about the proven effectiveness of:
Undiluted intracameral moxifloxacin
Effectiveness of Antibiotic Prophylaxis in Cataract surgery
Decreased postoperative endophthalmitis rate

Glaucoma Drops

TIMOLOL AND LATANOPROST

A fixed-combination solution dosed daily (at your physician’s instruction) for the reduction of intracoular pressure

TIMOLOL, BRIMONIDINE AND DORZOLAMIDE (AM FORMULA)

A fixed-combination solution for the reduction of intracoular pressure. This drop is dosed twice daily or, if used in conjunction with an evening dose of our PM formula, it can be dosed daily in the morning.

TIMOLOL, BRIMONIDINE, DORZOLAMIDE AND LATANOPROST (PM FORMULA)

A fixed-combination for the reduction of intraocular pressure. It is typically dosed in the evening, in conjunction with a morning dose of our AM formula.

DISCOVER THE BENEFITS OF OMNI™

Contact our sales department today to learn more about the exciting benefits of OMNI™ and how the product can positively impact your patients.

Learn More

Genesis™ (Amniotic Cytokine Extract Drop)

At Ocular Science™, we are committed to creating new ways of doing things. Our latest product, an amniotic cytokine extract eye drop, is the first of its kind for dry eye and wound healing. This drop can be safely stored in a home freezer while retaining its efficacy.

Genesis™ by Ocular Science™ is the first effective amniotic cytokine extract (ACE) for the treatment of ocular surface disease. Treatment of inflammation in dry eye disease is critical.  Cryopreserved amniotic eye drops contain more than 120 cytokines, growth factors and anti-inflammatory molecules to modulate and restore balance to the tear film. Key mediators include thrombospondin-1 (TSP-1), WNT4, PGE2 and GDF11. Amniotic tissue has been shown to modulate wound healing by mitigating the inflammatory cascade.  As it pertains to dry eye disease, ACE has the potential to modulate corneal and conjunctival epithelial healing, as well as modulate inflammation. Processing of amniotic extract is critical as the preservation of the key cytokines is essential to its efficacy.  ACE can be safely stored in a home freezer while retaining its efficacy.   The drop is used twice daily.

Read more about the proven effectiveness.

Read more about MSCs.

Learn More →

CONTACT US

Send us an Email

Name*
Email*
Phone
Subject*
Services

Message*

Ocular Science™
1334 Parkview Ave, ste 100
Manhattan Beach, CA 90266

Amy Castillo
Account Executive
Email: amcastillo@ocularscience.com
Phone: 310-662-3763